“Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2% Benzoyl Peroxide 3.1% Adapalene 0.15% Gel in Healthy Participants”. SKIN The Journal of Cutaneous Medicine 7, no. 4 (July 17, 2023): s227. Accessed October 24, 2025. https://skin.dermsquared.com/skin/article/view/2202.